What's new

Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised

Apr 22, 2025 - 15:19
 0
Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Business process description for pharmacovigilance

Next Article

Business process description for paediatric medicines development

Related Posts

Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Business process description for translations

Apr 22, 2025  0